Drug Utilization 90% Profile of Antibiotics Use during the Period of 2013 – 2017 at a Private Teaching Hospital in Yogyakarta

Saepudin Saepudin; Cinthia Sendysagita; Endang Yuniarti

doi:10.24071/jpsc.003061

Drug Utilization 90% Profile of Antibiotics Use during the Period of 2013 – 2017 at a Private Teaching Hospital in Yogyakarta

Saepudin Saepudin^(1*), Cinthia Sendysagita⁽²⁾, Endang Yuniarti⁽³⁾,

(1) Department of Pharmacy, Universitas Islam Indonesia, Yogyakarta
(2) Department of Pharmacy, Universitas Islam Indonesia, Yogyakarta
(3) PKU Muhammadiyah Hospital of Yogyakarta
(*) Corresponding Author

Abstract

Evaluation of antibiotics use plays an important role in antimicrobial stewardship programs to support the rational use of antibiotics at all healthcare facilities. This study aimed to describe the profile of drug utilization 90% (DU90%) of antibiotics use for hospitalized patients at a private teaching hospital in Yogyakarta over period of 2013 – 2017. Aggregate data of all systemic antibiotics having an anatomic therapeutic chemical (ATC) code and used for hospitalized patients during 2013 – 2017 were included in this study. Quantity of antibiotics use was expressed in defined daily dose (DDD) and final quantity was expressed in DDD/100 bed days. DU90% profile was obtained by calculating the cumulative use of antibiotics from the highest to the lowest percentage. There were 44 antibiotic agents used each year over the period of 2013 – 2017. However, there were only 10 – 12 agents within the DU90% segment. Cephalosporins group was identified as the most used antibiotics consistently over the period and the top three antibiotics that were consistently prescribed were: ceftriaxone, levofloxacin, and cefixime. It can be concluded that only about a quarter of the total antibiotic agents used in hospitals are within the DU90% segment and those antibiotic agents are relatively consistent, especially for the top three of the highest used antibiotics.

Keywords

anatomic therapeutic chemical/defined daily dose; antibiotics; drug utilization 90%

Full Text:

PDF

References

Álvarez, R., Cortés, L. E. L., Molina, J., Cisneros, J. M., and Pachón, J., 2016. Optimizing the clinical use of vancomycin: implications for drug monitoring. Antimicrobial Agents and Chemotherapy, 60(5), 2601–2609.

Barlam, T. F., Cosgrove, S. E., Abbo, L. M., Macdougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., Hamilton, C. W., Jenkins, T. C., Lipsett, P. A., Malani, P. N., May, L. S., Moran, G. J., Neuhauser, M. M., Newland, J. G., Ohl, C. A., … Trivedi, K. K., 2016. Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical Infectious Diseases, 62(10), e51–e77.

Bergman, U., Popa, C., Tomson, Y., Wettermark, B., Einarson, T. R., Åberg, H., and Sjöqvist, F., 1998. Drug utilization 90%: a simple method for assessing the quality of drug prescribing. European Journal of Clinical Pharmacology, 54(2), 113–118.

Cheng, A. C., Turnidge, J., Collignon, P., Looke, D., Barton, M., and Gottlieb, T., 2012. Control of fluoroquinolone resistance through successful regulation, Australia. Emerging Infectious Diseases, 18(9), 1453–1460.

Cusini, A., Rampini, S. K., Bansal, V., Ledergerber, B., Kuster, S. P., Ruef, C., and Weber, R., 2010. Different patterns of inappropriate antimicrobial use in surgical and medical units at a tertiary care hospital in Switzerland: a prevalence survey. PLoS ONE, 5(11), 1–8.

Davey, P., Scott, C. L., Brown, E., Charani, E., Michie, S., Ramsay, C. R., and Marwick, C. A., 2017. Interventions to improve antibiotic prescribing practices for hospital inpatients (updated protocol). Cochrane Database of Systematic Reviews, 2017(2).

Dreshaj, S., Doda-Ejupi, T., Tolaj, I. Q., Mustafa, A., Kabashi, S., Shala, N., Geca, N., Aliu, A., Daka, A., and Basha, N., 2011. Clinical role of cefixime in community-acquired infections. Prilozi, 32(2), 143–155.

Dyar, O. J., Huttner, B., Schouten, J., and Pulcini, C., 2017. What is antimicrobial stewardship? Clinical Microbiology and Infection, 23(11), 793–798.

Fauziyah, S., Radji, M., and Nurgani, A., 2011. Hubungan penggunaan antibiotika pada terapi empiris dengan kepekaan bakteri di ICU RSUP Fatmawati Jakarta. Jurnal Farmasi Indonesia, 5(3), 150–158.

Gallagher, J. C., Justo, J. A., Chahine, E. B., Bookstaver, P. B., Scheetz, M., Suda, K. J., Fehrenbacher, L., Klinker, K. P., and MacDougall, C., 2018. Preventing the post-antibiotic era by training future pharmacists as antimicrobial stewards. American Journal of Pharmaceutical Education, 82(6), 6770.

Kim, B., Hwang, H., Kim, J., Lee, M. J., and Pai, H., 2020. Ten-year trends in antibiotic usage at a tertiary care hospital in Korea, 2004 to 2013. Korean Journal of Internal Medicine, 35(3), 703–713.

Kim, B., Kim, Y., Hwang, H., Kim, J., Kim, S. W., Bae, I. G., Choi, W. S., Jung, S. I., Jeong, H. W., and Pai, H., 2018. Trends and correlation between antibiotic usage and resistance pattern among hospitalized patients at university hospitals in Korea, 2004 to 2012: A nationwide multicenter study. Medicine (United States), 97(51).

Klein, E. Y., Boeckel, T. P. Van, Martinez, E. M., Pant, S., Gandra, S., and Levin, S. A., 2018. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA, 115(15), 3463–3470.

Krockow, E. M., Colman, A. M., Chattoe-Brown, E., Jenkins, D. R., Perera, N., Mehtar, S., and Tarrant, C., 2019. Balancing the risks to individual and society: a systematic review and synthesis of qualitative research on antibiotic prescribing behaviour in hospitals. Journal of Hospital Infection, 101(4), 428–439.

Paterson, D. L., Ko, W., Gottberg, A. V. O. N., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., Cormack, J. G. M. C., and Yu, V. L., 2001. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. Journal of Clinical Microbiology, 39(6), 2206–2212.

Plüss-Suard, C., Pannatier, A., Kronenberg, A., Mühlemann, K., and Zanetti, G., 2011. Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe. Journal of Hospital Infection, 79(2), 166–171.

Qu, X., Yin, C., Sun, X., Huang, S., Li, C., Dong, P., Lu, X., Zhang, Z., and Yin, A., 2018. Consumption of antibiotics in Chinese public general tertiary hospitals (2011-2014): Trends , pattern changes and regional differences. PLoS ONE, 1–17.

Shallcross, L. J., Howard, S. J., Fowler, T., and Davies, S. C., 2015. Tackling the threat of antimicrobial resistance: From policy to sustainable action. Philosophical Transactions of the Royal Society B: Biological Sciences, 370(1670).

Sözen, H., Gönen, I., Sözen, A., Kutlucan, A., Kalemci, S., and Sahan, M., 2013. Application of ATC/DDD methodology to eveluate of antibiotic use in a general hospital in Turkey. Annals of Clinical Microbiology and Antimicrobials, 12(1), 2–7.

Tanvir, S. B., Qasim, S. S. Bin, Shariq, A., Najeeb, S., and Shah, A. H., 2018. Systematic review and meta-analysis on efficacy of cefixime for treating gonococcal infections. International Journal of Health Sciences, 12(5), 90–100. http://www.ncbi.nlm.nih.gov/pubmed/30202413%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6124830

Versporten, A., Zarb, P., Caniaux, I., Gros, M. F., Drapier, N., Miller, M., Jarlier, V., Nathwani, D., Goossens, H., Koraqi, A., Hoxha, I., Tafaj, S., Lacej, D., Hojman, M., Quiros, R. E., Ghazaryan, L., Cairns, K. A., Cheng, A., Horne, K. C., … May, S., 2018. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. The Lancet Global Health, 6(6), e619–e629.

Vu, T. V. D., Do, T. T. N., Rydell, U., Nilsson, L. E., Olson, L., Larsson, M., Hanberger, H., Choisy, M., Dao, T. T., van Doorn, H. R., Nguyen, V. K., Nguyen, V. T., and Wertheim, H. F. L., 2019. Antimicrobial susceptibility testing and antibiotic consumption results from 16 hospitals in Viet Nam: The VINARES project 2012–2013. Journal of Global Antimicrobial Resistance, 18, 269–278.

Wang, H., Wang, H., Yu, X., Zhou, H., Li, B., Chen, G., Ye, Z., Wang, Y., Cui, X., Zheng, Y., Zhao, R., Yang, H., Wang, Z., Wang, P., Yang, C., and Liu, L., 2019. Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010-2016: a retrospective observational study. BMJ Open, 9(8), 1–9.

World Health Organization, 2015. Global Action Plan on Antimicrobial Resistance. Microbe Magazine, 10(9), 354–355.

WHO Collaborating Centre for Drugs Statistics Methodology, 2021. Guidelines for ATC Classification and DDD assignment 2021, Oslo, Norway. available at https://www.whocc.no/filearchive/publications/2021_guidelines_web.pdf

Yang, P., Chen, Y., Jiang, S., Shen, P., Lu, X., and Xiao, Y., 2020. Association between the rate of fluoroquinolones-resistant gram-negative bacteria and antibiotic consumption from China based on 145 tertiary hospitals data in 2014. BMC Infectious Diseases, 20(1), 1–10.

DOI: https://doi.org/10.24071/jpsc.003061